SunTrust Stock Rating Lowered by UBS AG (STI)

SunTrust (NYSE: STI) was downgraded by stock analysts at UBS AG from a “buy” rating to a “neutral” rating in a report issued on Friday, TheFlyOnTheWall.com reports. The analysts noted that the move was a valuation call.

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet reiterated a “buy” rating on shares of SunTrust in a research note to investors on Tuesday, June 4th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of SunTrust in a research note to investors on Monday, June 3rd. They now have a $33.50 price target on the stock. Finally, analysts at Standpoint Research initiated coverage on shares of SunTrust in a research note to investors on Wednesday, May 29th. They set a “buy” rating and a $44.00 price target on the stock.

Two analysts have rated the stock with a sell rating, sixteen have given a hold rating and ten have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $31.48.

SunTrust (NYSE: STI) traded down 2.69% on Friday, hitting $31.09. SunTrust has a 1-year low of $21.72 and a 1-year high of $32.84. The stock’s 50-day moving average is currently $31.1. The company has a market cap of $16.654 billion and a price-to-earnings ratio of 8.50.

SunTrust (NYSE: STI) last issued its quarterly earnings data on Friday, April 19th. The company reported $0.63 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.62 by $0.01. The company had revenue of $2.11 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter last year, the company posted $0.46 earnings per share. SunTrust’s revenue was down 4.8% compared to the same quarter last year. Analysts expect that SunTrust will post $2.71 EPS for the current fiscal year.

SunTrust Banks, Inc. (NYSE: STI) is a commercial banking organization.

The Fly On The Wall

Latest News

Recro Pharma Inc  Expected to Post Earnings of -$0.75 Per Share
Recro Pharma Inc Expected to Post Earnings of -$0.75 Per Share
Analysts Anticipate Paylocity Holding Corp  to Announce $0.24 Earnings Per Share
Analysts Anticipate Paylocity Holding Corp to Announce $0.24 Earnings Per Share
La Jolla Pharmaceutical  Expected to Announce Quarterly Sales of $7.12 Million
La Jolla Pharmaceutical Expected to Announce Quarterly Sales of $7.12 Million
Webcoin Market Cap Tops $168,665.00
Webcoin Market Cap Tops $168,665.00
StockChain 24-Hour Trading Volume Reaches $73,685.00
StockChain 24-Hour Trading Volume Reaches $73,685.00
$2.03 EPS Expected for DXC Technology Co  This Quarter
$2.03 EPS Expected for DXC Technology Co This Quarter


© 2006-2018 Ticker Report